Search Results
Search for other papers by Yoshinori Kanemaru in
Google Scholar
PubMed
Search for other papers by Norio Harada in
Google Scholar
PubMed
Preemptive Medicine and Lifestyle Related Disease Research Center, Kyoto University Hospital, Kyoto, Japan
Search for other papers by Satoko Shimazu-Kuwahara in
Google Scholar
PubMed
Search for other papers by Shunsuke Yamane in
Google Scholar
PubMed
Search for other papers by Eri Ikeguchi in
Google Scholar
PubMed
Search for other papers by Yuki Murata in
Google Scholar
PubMed
Search for other papers by Sakura Kiyobayashi in
Google Scholar
PubMed
Search for other papers by Tomonobu Hatoko in
Google Scholar
PubMed
Search for other papers by Nobuya Inagaki in
Google Scholar
PubMed
decline of activities of daily living (ADL) in elderly people and is also related to the high prevalence of medical disorders such as diabetes, hyperlipidemia, and hypertension ( Cheng et al . 2013 , Chang et al . 2017 ). It is therefore important for
Department of Veterinary Basic Sciences, Diabetes and Obesity Research Program, Faculty of Medicine, Department of Medicine, Faculty of Medicine, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK
Search for other papers by M E Cleasby in
Google Scholar
PubMed
Search for other papers by Q Lau in
Google Scholar
PubMed
Search for other papers by E Polkinghorne in
Google Scholar
PubMed
Search for other papers by S A Patel in
Google Scholar
PubMed
Search for other papers by S J Leslie in
Google Scholar
PubMed
Department of Veterinary Basic Sciences, Diabetes and Obesity Research Program, Faculty of Medicine, Department of Medicine, Faculty of Medicine, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK
Search for other papers by N Turner in
Google Scholar
PubMed
Department of Veterinary Basic Sciences, Diabetes and Obesity Research Program, Faculty of Medicine, Department of Medicine, Faculty of Medicine, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK
Search for other papers by G J Cooney in
Google Scholar
PubMed
Search for other papers by A Xu in
Google Scholar
PubMed
Department of Veterinary Basic Sciences, Diabetes and Obesity Research Program, Faculty of Medicine, Department of Medicine, Faculty of Medicine, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK
Search for other papers by E W Kraegen in
Google Scholar
PubMed
Introduction Resistance of skeletal muscle to the action of insulin is an essential pre-requisite for the development of type 2 diabetes and is frequently associated with obesity ( Zimmet et al . 2001 ). This insulin resistance has been
Search for other papers by S Khan in
Google Scholar
PubMed
Centre for Discovery Brain Science, University of Edinburgh, Hugh Robson Building, Edinburgh, UK
Search for other papers by D E W Livingstone in
Google Scholar
PubMed
Search for other papers by A Zielinska in
Google Scholar
PubMed
Search for other papers by C L Doig in
Google Scholar
PubMed
Search for other papers by D F Cobice in
Google Scholar
PubMed
Search for other papers by C L Esteves in
Google Scholar
PubMed
Search for other papers by J T Y Man in
Google Scholar
PubMed
Search for other papers by N Z M Homer in
Google Scholar
PubMed
Search for other papers by J R Seckl in
Google Scholar
PubMed
Search for other papers by C L MacKay in
Google Scholar
PubMed
Search for other papers by S P Webster in
Google Scholar
PubMed
Search for other papers by G G Lavery in
Google Scholar
PubMed
Search for other papers by K E Chapman in
Google Scholar
PubMed
Clinical & Translational Research Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
Search for other papers by B R Walker in
Google Scholar
PubMed
Mass Spectrometry Core Laboratory, Edinburgh Clinical Research Facility, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
Search for other papers by R Andrew in
Google Scholar
PubMed
effects including type 2 diabetes, hypertension, visceral obesity, myopathy, mood disturbances and cognitive deficits, and 11βHSD1 has therefore emerged as a drug target to reduce active glucocorticoid levels ( Hughes et al. 2008 ) in a tissue
Search for other papers by Graham W Aberdeen in
Google Scholar
PubMed
Search for other papers by Jeffery S Babischkin in
Google Scholar
PubMed
Search for other papers by Gerald J Pepe in
Google Scholar
PubMed
Search for other papers by Eugene D Albrecht in
Google Scholar
PubMed
Introduction There is a prevalent increase in the incidence of type 2 diabetes mellitus (T2DM), particularly in the younger generation, in the USA ( Cowie et al. 2018 , Lin et al. 2020 ). However, little is known about the cause of this
VCA Colonial Animal Hospital, Ithaca, New York, USA
Search for other papers by Michael Merkhassine in
Google Scholar
PubMed
Weill Cornell College of Medicine, New York, New York, USA
Search for other papers by Reilly W Coch in
Google Scholar
PubMed
Search for other papers by Carol E Frederick in
Google Scholar
PubMed
Search for other papers by Lucinda L Bennett in
Google Scholar
PubMed
Fate Therapeutics, San Diego, California, USA
Search for other papers by Seth A Peng in
Google Scholar
PubMed
Search for other papers by Benjamin Morse in
Google Scholar
PubMed
Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA
Search for other papers by Bethany P Cummings in
Google Scholar
PubMed
Search for other papers by John P Loftus in
Google Scholar
PubMed
as an antidote for hypoglycemia caused by exogenous insulin administration ( Datte et al. 2016 , Harris et al. 2020 ). Elevated glucagon levels are seen in virtually all forms of diabetes mellitus (DM), α-cell hyperplasia, and, most dramatically
Search for other papers by Eun Young Lee in
Google Scholar
PubMed
Search for other papers by Shuji Kaneko in
Google Scholar
PubMed
Search for other papers by Promsuk Jutabha in
Google Scholar
PubMed
Search for other papers by Xilin Zhang in
Google Scholar
PubMed
Search for other papers by Susumu Seino in
Google Scholar
PubMed
Search for other papers by Takahito Jomori in
Google Scholar
PubMed
Search for other papers by Naohiko Anzai in
Google Scholar
PubMed
Search for other papers by Takashi Miki in
Google Scholar
PubMed
type 2 diabetes mellitus (T2DM; Cho et al . 2014 ). GLP1-targeted anti-diabetic agents comprise GLP1 mimetics and inhibitors of dipeptidyl peptidase 4 that enhance GLP1 action by inhibiting the rapid inactivation of the hormone endogenously secreted
Department of Anatomy, Department of Medicine, Integrated Metabolomics Research Group, Department of Life Science, Korea University College of Medicine, Seoul 136-701, South Korea
Search for other papers by Nami Kim in
Google Scholar
PubMed
Search for other papers by Jung Ok Lee in
Google Scholar
PubMed
Search for other papers by Hye Jeong Lee in
Google Scholar
PubMed
Search for other papers by Yong Woo Lee in
Google Scholar
PubMed
Search for other papers by Hyung Ip Kim in
Google Scholar
PubMed
Search for other papers by Su Jin Kim in
Google Scholar
PubMed
Search for other papers by Sun Hwa Park in
Google Scholar
PubMed
Search for other papers by Chul Su Lee in
Google Scholar
PubMed
Search for other papers by Sun Woo Ryoo in
Google Scholar
PubMed
Department of Anatomy, Department of Medicine, Integrated Metabolomics Research Group, Department of Life Science, Korea University College of Medicine, Seoul 136-701, South Korea
Search for other papers by Geum-Sook Hwang in
Google Scholar
PubMed
Search for other papers by Hyeon Soo Kim in
Google Scholar
PubMed
and diabetes. Contraction of the skeletal muscles stimulates GLUT4 translocation in an insulin-independent manner ( Lund et al . 1995 ). Because glucose uptake during muscle contraction occurs in the absence of insulin, it is suggested that insulin
The National Institute of Biotechnology in the Negev (NIBN), Ben-Gurion University, Beer-Sheva, Israel
Search for other papers by Maayan Vatarescu in
Google Scholar
PubMed
The National Institute of Biotechnology in the Negev (NIBN), Ben-Gurion University, Beer-Sheva, Israel
Search for other papers by Sapir Bechor in
Google Scholar
PubMed
The National Institute of Biotechnology in the Negev (NIBN), Ben-Gurion University, Beer-Sheva, Israel
Search for other papers by Yulia Haim in
Google Scholar
PubMed
The National Institute of Biotechnology in the Negev (NIBN), Ben-Gurion University, Beer-Sheva, Israel
Search for other papers by Tal Pecht in
Google Scholar
PubMed
Search for other papers by Tanya Tarnovscki in
Google Scholar
PubMed
Search for other papers by Noa Slutsky in
Google Scholar
PubMed
Search for other papers by Ori Nov in
Google Scholar
PubMed
Search for other papers by Hagit Shapiro in
Google Scholar
PubMed
Search for other papers by Avishai Shemesh in
Google Scholar
PubMed
Search for other papers by Angel Porgador in
Google Scholar
PubMed
Search for other papers by Nava Bashan in
Google Scholar
PubMed
The National Institute of Biotechnology in the Negev (NIBN), Ben-Gurion University, Beer-Sheva, Israel
Search for other papers by Assaf Rudich in
Google Scholar
PubMed
mechanisms ( Cho 2014 ). Clearly, resolution of obesity itself is not required for this metabolic improvement, which in some patients even results in remission of preoperative overt type 2 diabetes. Moreover, when inducing weight loss in HFF mice, dysglycemia
Search for other papers by Sian J S Simpson in
Google Scholar
PubMed
Search for other papers by Lorna I F Smith in
Google Scholar
PubMed
Search for other papers by Peter M Jones in
Google Scholar
PubMed
Search for other papers by James E Bowe in
Google Scholar
PubMed
functional β-cell mass and enhanced insulin secretory responses ( Baeyens et al . 2016 ). Failure of the β-cell to adapt to the maternal metabolic load can lead to maternal glucose intolerance and, eventually, to overt gestational diabetes ( Zhang et al
Search for other papers by I J Bujalska in
Google Scholar
PubMed
Search for other papers by L L Gathercole in
Google Scholar
PubMed
Search for other papers by J W Tomlinson in
Google Scholar
PubMed
Search for other papers by C Darimont in
Google Scholar
PubMed
Search for other papers by J Ermolieff in
Google Scholar
PubMed
Search for other papers by A N Fanjul in
Google Scholar
PubMed
Search for other papers by P A Rejto in
Google Scholar
PubMed
Search for other papers by P M Stewart in
Google Scholar
PubMed
Introduction Glucocorticoid excess (Cushing's syndrome) causes visceral obesity, insulin resistance, diabetes mellitus, dyslipidaemia, hypertension and premature vascular mortality; as such it represents an excellent paradigm for patients with the